Dr Meunier, whose PhD thesis at Paris University concentrated on nerve cell conversation, furthered his passions in the field during postdoctoral research at Imperial University, London on synaptic analysis, and on phosphate-comprising lipids in cancer study at the Medical Study Council Laboratory of Molecular Biology in Cambridge, an institute which includes produced a lot more than 13 Nobel Prize winners. He joined UQ 2 yrs ago after a possibility ending up in Professor David Adams of UQ’s College of Biomedical Sciences at a global conference..SOURCE Boston Scientific Corporation.
Clinical study data on Mallinckrodt’s H.P. Gel to be offered at ACR 2015 Acthar Mallinckrodt plc , a respected specialty biopharmaceutical company, today announced that data from a pilot study for its H.P. Acthar Gel will be presented at the American University of Rheumatology 2015 Annual Meeting to become held November 7-11 in San Francisco. The company-sponsored pilot study, titled ‘Repository Corticotropin Injection Attenuates Disease Activity in Sufferers with Persistently Dynamic Systemic Lupus Erythematosus Needing Corticosteroids,’ was an eight-week, double-blind, randomized, placebo-controlled research that assessed clinical efficacy of repository corticotropin injection in sufferers with persistently active SLE despite moderate dose corticosteroids.